Academic literature on the topic 'Cancer molecular targets'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Cancer molecular targets.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Cancer molecular targets"
Weigelt, Britta, and Susana Banerjee. "Molecular targets and targeted therapeutics in endometrial cancer." Current Opinion in Oncology 24, no. 5 (September 2012): 554–63. http://dx.doi.org/10.1097/cco.0b013e328354e585.
Full textKummar, Shivaani, and James H. Doroshow. "Molecular targets in cancer therapy." Expert Review of Anticancer Therapy 13, no. 3 (March 2013): 267–69. http://dx.doi.org/10.1586/era.12.170.
Full textLorch, Jochen H. "Molecular Targets for Thyroid Cancer." Oncology Times 35 (June 2013): 2–3. http://dx.doi.org/10.1097/01.cot.0000431825.52663.3e.
Full textLazo, John S., and Elizabeth R. Sharlow. "Drugging Undruggable Molecular Cancer Targets." Annual Review of Pharmacology and Toxicology 56, no. 1 (January 6, 2016): 23–40. http://dx.doi.org/10.1146/annurev-pharmtox-010715-103440.
Full textGale, Danielle M. "Molecular targets in cancer therapy." Seminars in Oncology Nursing 19, no. 3 (August 2003): 193–205. http://dx.doi.org/10.1016/s0749-2081(03)00047-0.
Full textWestwell, Andrew D. "Molecular targets and cancer therapeutics." Drug Discovery Today 9, no. 24 (December 2004): 1042–44. http://dx.doi.org/10.1016/s1359-6446(04)03287-8.
Full textWilliam, William N., John V. Heymach, Edward S. Kim, and Scott M. Lippman. "Molecular targets for cancer chemoprevention." Nature Reviews Drug Discovery 8, no. 3 (March 2009): 213–25. http://dx.doi.org/10.1038/nrd2663.
Full textZaenker, K. S., G. Mustacchi, and E. Mihich. "Molecular targets of cancer chemotherapy." Cancer Chemotherapy and Pharmacology 58, no. 2 (December 24, 2005): 279–82. http://dx.doi.org/10.1007/s00280-005-0170-9.
Full textRossig, Claudia. "Immune modulation by molecular cancer targets and targeted therapies." OncoImmunology 1, no. 3 (May 2012): 358–60. http://dx.doi.org/10.4161/onci.18401.
Full textWang, Shihao, Jinqiu Shen, Boyang Zhang, Jiao Tian, Wei Zhao, and Wenzheng Wu. "Molecular mechanism study of cancer treatment based on network pharmacology of lily." Highlights in Science, Engineering and Technology 14 (September 29, 2022): 397–403. http://dx.doi.org/10.54097/hset.v14i.1852.
Full textDissertations / Theses on the topic "Cancer molecular targets"
Culp, W. David. "Identifying molecular targets for cancer therapy /." Stockholm, 2007. http://diss.kib.ki.se/2007/978-91-7357-188-3/.
Full textEhsanian, Reza. "Molecular targets in head and neck cancer." Thesis, University of Oxford, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.540135.
Full textQureishi, Ali Akhtar Siddique. "Molecular targets in head and neck cancer." Thesis, King's College London (University of London), 2017. https://kclpure.kcl.ac.uk/portal/en/theses/molecular-targets-in-head-and-neck-cancer(f4b44db3-7db7-4ed6-8b8d-77d3d446b116).html.
Full textCampbell, Paul Michael. "DNA methylation machinery as molecular targets for cancer therapeutics." Thesis, McGill University, 2002. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=82836.
Full textTarrado, Castellarnau Miriam. "Targeting metabolic reprogramming associated to cancer cells: search of novel targets and combined therapies in cancer treatment." Doctoral thesis, Universitat de Barcelona, 2015. http://hdl.handle.net/10803/385425.
Full textWong, Ka-wing, and 王家穎. "Study of potential targets of miR-143 in cervical cancer." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2014. http://hdl.handle.net/10722/206496.
Full textpublished_or_final_version
Pathology
Master
Master of Medical Sciences
Bachelor, Michael A. "Identification of molecular targets for the chemoprevention of non-melanoma skin cancer." Diss., The University of Arizona, 2004. http://hdl.handle.net/10150/280585.
Full textWhetstone, Jennifer Lynn. "Identification of synthetic benzopyranones as selective agents for molecular targets in breast cancer /." The Ohio State University, 2001. http://rave.ohiolink.edu/etdc/view?acc_num=osu1486401895209686.
Full textOng, Chee Wee. "Clinical and molecular characterisation of prognostic markers and therapeutic targets in prostate cancer." Thesis, Queen's University Belfast, 2016. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.709689.
Full textAlfarsi, Halema. "In silico mutagenesis and 3D culture appraoch to define molecular targets in ovarian cancer." Thesis, Université Paris-Saclay (ComUE), 2015. http://www.theses.fr/2015SACLS104.
Full textOvarian cancer causes more deaths in the United States than any other type of female reproductive tract cancer, with an estimated 21,980 new cases and 14,270 deaths in 2014. Approximately 70% of ovarian cancers are diagnosed at advanced stage and only 30% of women with such cancers can expect to survive 5 years. This low survival rate is due to the frequent diagnosis of epithelial ovarian cancer at an advanced stage, and to intrinsic and acquired resistance to platinum-based chemotherapy. Clinical and pathological classification methods, including tumor grade and the extent of surgical debulking, still fail to fully predict disease progression and patient outcome. Clinical profile of initial response to chemotherapy in the majority of patients followed by recurrence in high proportion of patients suggests the presence of a subpopulation of cells that survives and leads to chemoresistance. Only by treating this subpopulation we can achieve durable response rates.Genomic instability is a hallmark of malignant tumors, causing disturbed integrity of the genome, numerical alterations, and structural changes. For various cancer types greater genomic instability has been associated with poor prognosis, suggesting that genomic instability may confer growth advantage of cancer cells. With the recent development of next-generation sequencing (NGS) technology, the Cancer Genome Atlas (TCGA) researchers have identified molecular abnormalities related to the pathophysiology, clinical outcome, and potential therapeutic targets in high-grade serous ovarian cancer (HGSC). The TCGA study provides a large-scale integrative view of the aberration in HGSC with extensive heterogeneity between individual tumorsOur research protocols enabled us to combine computational biology approach and gene knock down in the first part to identify genes that play an important role in ovarian cancer biology. we carried out in silico mutagenesis of the human genome corresponding to the regions sequenced by publically available ovarian cancer sequencing data from the TCGA. We compared the simulated mutations to the observed mutations in the TCGA cohort. We found genes that were observed to be mutated less than expected from the simulation data.Our approach allowed us to identify therefore a set of genes that we think are selected and remain unmutated for their potential role in tumor progression. Silencing of un-mutated genes impacted growth, morphology, migration, invasion and chemotherapeutic. This is the first study depicting that inhibition of a specific non-mutated gene by its single targeting siRNA can be utilized to obtain improved therapeutic efficiency
Books on the topic "Cancer molecular targets"
E, Steele Vernon, ed. Cellular and molecular targets for chemoprevention. Boca Raton, Fla: CRC Press, 1992.
Find full textChatterjee, Malay, ed. Molecular Targets and Strategies in Cancer Prevention. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-31254-5.
Full textChatterjee, Malay, and Khosrow Kashfi, eds. Cell Signaling & Molecular Targets in Cancer. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-0730-0.
Full textPecorino, Lauren. Molecular biology of cancer: Mechanisms, targets, and therapeutics. Oxford: Oxford University Press, 2005.
Find full textPecorino, Lauren. Molecular biology of cancer: Mechanisms, targets, and therapeutics. 2nd ed. Oxford: Oxford University Press, 2008.
Find full textPecorino, Lauren. Molecular biology of cancer: Mechanisms, targets, and therapeutics. 2nd ed. Oxford: Oxford University Press, 2008.
Find full textPecorino, Lauren. Molecular biology of cancer: Mechanisms, targets, and therapeutics. 2nd ed. Oxford: Oxford University Press, 2008.
Find full textPecorino, Lauren. Molecular biology of cancer: Mechanisms, targets, and therapeutics. 2nd ed. Oxford: Oxford University Press, 2008.
Find full textKelley, Mark Richard. DNA repair in cancer therapy: Molecular targets and clinical applications. London: Elsevier/Academic Press, 2012.
Find full textDNA repair in cancer therapy: Molecular targets and clinical applications. London: Elsevier/Academic Press, 2012.
Find full textBook chapters on the topic "Cancer molecular targets"
Annunziata, Christina M., and Phillip A. Dennis. "Molecular Targets." In Cancer Drug Discovery and Development, 1–21. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-9135-4_1.
Full textDumitrescu, Ramona G. "Epigenetic Targets in Cancer Epidemiology." In Methods in Molecular Biology, 457–67. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-59745-416-2_23.
Full textHochwald, Steven N., William G. Cance, and Elena Kurenova. "Pancreatic Cancer: Molecular Targets for Therapy." In Encyclopedia of Cancer, 1–7. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-27841-9_4358-4.
Full textHochwald, Steven N., William G. Cance, and Elena Kurenova. "Pancreatic Cancer Molecular Targets for Therapy." In Encyclopedia of Cancer, 3421–27. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-46875-3_4358.
Full textHochwald, Steven N., Elena Kurenova, and William G. Cance. "Pancreas Cancer Molecular Targets for Therapy." In Encyclopedia of Cancer, 2770–76. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-16483-5_4358.
Full textUnver, Nese, and Chirayu Mohindroo. "Targets and Strategies for Cancer Immunoprevention." In Methods in Molecular Biology, 7–17. New York, NY: Springer US, 2022. http://dx.doi.org/10.1007/978-1-0716-2014-4_2.
Full textCappello, Paola, Sara Bulfamante, Giorgia Mandili, and Francesco Novelli. "Discovery of Targets for Cancer Immunoprevention." In Methods in Molecular Biology, 19–33. New York, NY: Springer US, 2022. http://dx.doi.org/10.1007/978-1-0716-2014-4_3.
Full textAyriss, Joanne E., Chien-Tsun Kuan, Susan T. Boulton, David A. Reardon, and Darell D. Bigner. "Molecular Targets for Antibody-Mediated Immunotherapy of Malignant Glioma." In CNS Cancer, 865–98. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-553-8_36.
Full textBronchud, Miguel H. "Selecting the Right Targets for Cancer Therapy." In Principles of Molecular Oncology, 1–26. Totowa, NJ: Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-470-4_1.
Full textBronchud, Miguel H. "Selecting the Right Targets for Cancer Therapy." In Principles of Molecular Oncology, 3–49. Totowa, NJ: Humana Press, 2004. http://dx.doi.org/10.1007/978-1-59259-664-5_1.
Full textConference papers on the topic "Cancer molecular targets"
Brown, Powel H. "Abstract ED02-01: Molecular targets of cancer preventive agents." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 15-19, 2009; Boston, MA. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/1535-7163.targ-09-ed02-01.
Full textKobayashi, Hisataka. "Near infrared photoimmunotherapy for cancer; New targets on cancer and immune-suppressive cells." In Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications XIII, edited by Samuel Achilefu and Ramesh Raghavachari. SPIE, 2021. http://dx.doi.org/10.1117/12.2577639.
Full textKomseli, Eirini-Stavroula, Fabiola Sesti, Konstantinos Evangelou, Christina Cheimonidou, Athanassios Kotsinas, Vassilis Gorgoulis, and Ioannis P. Trougakos. "Abstract B73: Proteostasis network modules as molecular targets for cancer therapeutics." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Oct 19-23, 2013; Boston, MA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1535-7163.targ-13-b73.
Full textMerchant, Kendra T., Appu Rathinavelu, James Kumi‐Diaka, Nwadiuto Esiobu, Robert Zoeller, James Hartmann, and Michelle Johnson. "Abstract C85: Novel molecular targets for genistein in prostate cancer cells." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 15-19, 2009; Boston, MA. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/1535-7163.targ-09-c85.
Full textStangeland, Biljana, Mrinal Joel, Awais Mughal, Zanina Grieg, Ingunn Ramsnes, Staale Nygaard, Cecilie Sandberg, et al. "Abstract B202: Identification of new molecular targets in glioblastoma." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 12-16, 2011; San Francisco, CA. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1535-7163.targ-11-b202.
Full textKolev, Vihren, Yan Wang, Kam Sprott, Irina Shapiro, Jennifer Ring, Jonathan Pachter, and David Weaver. "Abstract C29: FAK inhibition targets cancer stem cells." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; November 5-9, 2015; Boston, MA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1535-7163.targ-15-c29.
Full textToyoshima, Masafumi, Heather Howie, Maki Imakura, Ryan Walsh, Julie Park, and Carla Grandori. "Abstract C135: Therapeutic targets for MYC-driven cancer." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 12-16, 2011; San Francisco, CA. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1535-7163.targ-11-c135.
Full textEdgren, Henrik, Kalle Ojala, and Anja Ruusulehto. "Abstract A75: Pan-cancer identification of fusion genes as therapeutic targets in cancer." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; November 5-9, 2015; Boston, MA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1535-7163.targ-15-a75.
Full textYoshino, Hirofumi, Hideki Enokida, Takeshi Yamasaki, Hideo Hidaka, Takeshi Chiyomaru, Nijiro Nohata, Naohiko Seki, and Masayuki Nakagawa. "Abstract 1103: Molecular targets regulated by tumor suppressivemicroRNA-1andmicroRNA-133ain bladder cancer." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-1103.
Full textLi, Rick, Shenshen Lai, Allan Mah, Hong Zhang, Jun Yan, Anthony Marotta, and Zaihui Zhang. "Abstract A152: Emerging indications for kinase-targeted therapies: screening for new targets." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; October 26-30, 2017; Philadelphia, PA. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1535-7163.targ-17-a152.
Full textReports on the topic "Cancer molecular targets"
Verma, Ajit K. Molecular Targets for Prevention of Prostate Cancer. Fort Belvoir, VA: Defense Technical Information Center, December 2009. http://dx.doi.org/10.21236/ada538690.
Full textWang, Lu-Hai. Exploring the Molecular Targets for Breast Cancer Therapy. Fort Belvoir, VA: Defense Technical Information Center, April 2005. http://dx.doi.org/10.21236/ada442297.
Full textVerma, Ajit K. Molecular Targets for the Prevention of Prostate Cancer. Fort Belvoir, VA: Defense Technical Information Center, December 2008. http://dx.doi.org/10.21236/ada497253.
Full textWahl, Geoffrey M. Amplified Genes in Breast Cancer: Molecular Targets for Investigation and Therapy. Fort Belvoir, VA: Defense Technical Information Center, September 1999. http://dx.doi.org/10.21236/ada382811.
Full textRoper, Justin R. Onboard SPECT for Localizing Functional and Molecular Targets in Metastatic Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, July 2009. http://dx.doi.org/10.21236/ada509347.
Full textHong, Waun K., and Roy Herbst. Imaging and Molecular Markers for Patients with Lung Cancer: Approaches with Molecular Targets, Complementary/Innovative Treatment, and Therapeutic Modalities. Fort Belvoir, VA: Defense Technical Information Center, February 2011. http://dx.doi.org/10.21236/ada548594.
Full textHong, Waun Ki, and Roy Herbst. IMPACT (Imaging and Molecular Markers for Patients with Lung Cancer: Approaches with Molecular Targets and Complementary, Innovative and Therapeutic Modalities). Fort Belvoir, VA: Defense Technical Information Center, March 2006. http://dx.doi.org/10.21236/ada485809.
Full textHong, Waun K., and Roy Herbst. IMPACT (Imaging and Molecular Markers for Patients with Lung Cancer: Approaches with Molecular Targets and Complementary, Innovative and Therapeutic Modalities). Fort Belvoir, VA: Defense Technical Information Center, March 2009. http://dx.doi.org/10.21236/ada504658.
Full textHong, Waun K. IMPACT: Imaging and Molecular Markers for Patients with Lung Cancer: Approaches with Molecular Targets, Complementary/Innovative Treatments, and Therapeutic Modalities. Fort Belvoir, VA: Defense Technical Information Center, February 2013. http://dx.doi.org/10.21236/ada579142.
Full textHong, Waun K. IMPACT: Imaging and Molecular Markers for Patients with Lung Cancer: Approaches with Molecular Targets, Complementary/Innovative Treatments, and Therapeutic Modalities. Fort Belvoir, VA: Defense Technical Information Center, February 2014. http://dx.doi.org/10.21236/ada602577.
Full text